Not provided
Not provided
Not provided
Not provided
Not provided
Difficulty enrolling participants due to exclusion and inclusion criteria
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This project aims to treat field cancerization ( pre-skin cancers) in a manner that will reduce the future pre-skin cancers and non-melanoma skin cancers in patients with significant photodamage.
This is 3 year prospective, randomized, controlled comparison of a single treatment with carbon dioxide laser resurfacing vs. carbon dioxide resurfacing plus autologous epidermal skin graft from a non sun exposed site vs. control.
Thirty subjects will receive treatment with each of the modalities.
The primary measures of efficacy are (a) count of the number of actinic keratosis and non melanoma skin cancers, (b) blinded evaluation of severity from standard digital photographs taken before and after the treatments, and (c) change in histology before and after treatment. Safety measures include (a) pain, (b) scarring, (c) wound healing, (d) and infection
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ultrapulse laser alone | Active Comparator |
| |
| Ultrapulse laser plus Cellutome Harvesting system | Active Comparator |
| |
| Control | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ultrapulse Carbon Dioxide Laser | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Count of the Number of Actinic Keratosis and Non Melanoma Skin Cancers in the Treatment Area | This is done at every visit over the 3 year period | Entire study period (3 years) |
Not provided
Not provided
Inclusion criteria
Exclusion criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Rox Anderson, MD | Massachusetts General Hospital/ Wellman Center for Photomedicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Ultrapulse Laser Alone | Ultrapulse Carbon Dioxide Laser |
| FG001 | Ultrapulse Laser Plus Cellutome Harvesting System | Ultrapulse Carbon Dioxide Laser Cellutome epidermal harvesting system |
| FG002 | Control | Control group, no treatment |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
There was only one patient enrolled in this study
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Ultrapulse Laser Alone | Ultrapulse Carbon Dioxide Laser |
| BG001 | Ultrapulse Laser Plus Cellutome Harvesting System | Ultrapulse Carbon Dioxide Laser Cellutome epidermal harvesting system |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Count of the Number of Actinic Keratosis and Non Melanoma Skin Cancers in the Treatment Area | This is done at every visit over the 3 year period | Zero participants were analyzed because no patients finished this study. Patient recruitment was very difficult for this study, and therefore the study ended prematurely. | Posted | Entire study period (3 years) |
|
The time the patient was in the study, 6 months
For areas where participants at risk is 0, it is because there were no participants in these categories.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Ultrapulse Laser Alone | Ultrapulse Carbon Dioxide Laser | 0 |
Not provided
Not provided
Recruitment was very difficult for this study. Due to long study period, patient retention was also difficult. The study was terminated because of low recruitment. One subject started the study and was lost to follow-up, without completing the study.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Elizabeth Morehouse, Clinical Research Coordinator | Massachusetts General Hospital | 617-724-2168 | emorehouse@partners.org |
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Dec 28, 2016 | Oct 11, 2019 | Prot_000.pdf |
Not provided
| ID | Term |
|---|---|
| D055623 | Keratosis, Actinic |
| ID | Term |
|---|---|
| D011230 | Precancerous Conditions |
| D009369 | Neoplasms |
| D007642 | Keratosis |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Cellutome epidermal harvesting system | Device |
|
| BG002 | Control | Control group |
| BG003 | Total | Total of all reporting groups |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
| OG002 |
| Control |
Control group (no laser or CelluTome) |
|
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| EG001 | Ultrapulse Laser Plus Cellutome Harvesting System | Ultrapulse Carbon Dioxide Laser Cellutome epidermal harvesting system | 0 | 1 | 0 | 1 | 0 | 1 |
| EG002 | Control | Control site | 0 | 0 | 0 | 0 | 0 | 0 |
Not provided
Not provided
Not provided
| D017437 |
| Skin and Connective Tissue Diseases |